Invited speaker discusses Alzheimer’s disease at HudsonAlpha research seminar series

HudsonAlpha virtually welcomed Erik Roberson, MD, PhD, as the first seminar speaker for the 2022 Research Seminar series. Dr. Roberson is a Rebecca Gale Endowed Professor in the departments of Neurology and Neurobiology at the University of Alabama at Birmingham. He is also Director of the Alzheimer’s Disease Center and Director of the Center for Neurodegeneration and Experimental Therapeutics. HudsonAlpha Faculty Investigator Nick Cochran, PhD, hosted the seminar.

In his talk entitled “Targeting Tau-SH3 Interactions for Alzheimer’s Disease”, Dr. Roberson discussed his work on the neurobiology of Alzheimer’s disease and frontotemporal dementia. His talk focused on projects relating to the role of tau and its binding partners in neuronal dysfunction in Alzheimer’s disease. He also discussed potential treatments for Alzheimer’s disease network hyperexcitability.

To learn more about these projects and Dr. Roberson’s other research interests, visit his lab’s website here.

More information on HudsonAlpha Research Seminars, including the upcoming schedule, can be found at